Cargando…
Correction: Structural Characterization of a Therapeutic Anti-Methamphetamine Antibody Fragment: Oligomerization and Binding of Active Metabolites
Autores principales: | Peterson, Eric C., Celikel, Reha, Gokulan, Kuppan, Varughese, Kottayil I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3879017/ http://dx.doi.org/10.1371/annotation/f92e9067-daee-45af-b5da-5779273225ed |
Ejemplares similares
-
Structural Characterization of a Therapeutic Anti-Methamphetamine Antibody Fragment: Oligomerization and Binding of Active Metabolites
por: Peterson, Eric C., et al.
Publicado: (2013) -
Affinity improvement of a therapeutic antibody to methamphetamine and
amphetamine through structure-based antibody engineering
por: Thakkar, Shraddha, et al.
Publicado: (2014) -
Structure-based Design Targeted at LOX-1, a Receptor for Oxidized Low-Density Lipoprotein
por: Thakkar, Shraddha, et al.
Publicado: (2015) -
A Nanotechnology-Based Platform for Extending the Pharmacokinetic and Binding Properties of Anti-methamphetamine Antibody Fragments
por: Nanaware-Kharade, Nisha, et al.
Publicado: (2015) -
Correction: The Anti-(+)-Methamphetamine Monoclonal Antibody mAb7F9 Attenuates Acute (+)-Methamphetamine Effects on Intracranial Self-Stimulation in Rats
por: Harris, Andrew C., et al.
Publicado: (2015)